162 related articles for article (PubMed ID: 15459946)
1. Contribution of the paracellular route to the pH-dependent epithelial permeability to cationic drugs.
Nagahara N; Tavelin S; Artursson P
J Pharm Sci; 2004 Dec; 93(12):2972-84. PubMed ID: 15459946
[TBL] [Abstract][Full Text] [Related]
2. The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Tam KY; Avdeef A; Tsinman O; Sun N
J Med Chem; 2010 Jan; 53(1):392-401. PubMed ID: 19947605
[TBL] [Abstract][Full Text] [Related]
3. Exploring the role of different drug transport routes in permeability screening.
Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
[TBL] [Abstract][Full Text] [Related]
4. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.
Avdeef A; Artursson P; Neuhoff S; Lazorova L; Gråsjö J; Tavelin S
Eur J Pharm Sci; 2005 Mar; 24(4):333-49. PubMed ID: 15734300
[TBL] [Abstract][Full Text] [Related]
5. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs.
Palm K; Luthman K; Ros J; Grasjo J; Artursson P
J Pharmacol Exp Ther; 1999 Nov; 291(2):435-43. PubMed ID: 10525056
[TBL] [Abstract][Full Text] [Related]
6. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
[TBL] [Abstract][Full Text] [Related]
7. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
[TBL] [Abstract][Full Text] [Related]
8. Correction of permeability with pore radius of tight junctions in Caco-2 monolayers improves the prediction of the dose fraction of hydrophilic drugs absorbed by humans.
Saitoh R; Sugano K; Takata N; Tachibana T; Higashida A; Nabuchi Y; Aso Y
Pharm Res; 2004 May; 21(5):749-55. PubMed ID: 15180329
[TBL] [Abstract][Full Text] [Related]
9. A new in vitro system for evaluation of passive intestinal drug absorption: establishment of a double artificial membrane permeation assay.
Kataoka M; Tsuneishi S; Maeda Y; Masaoka Y; Sakuma S; Yamashita S
Eur J Pharm Biopharm; 2014 Nov; 88(3):840-6. PubMed ID: 25304077
[TBL] [Abstract][Full Text] [Related]
10. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model.
Pade V; Stavchansky S
Pharm Res; 1997 Sep; 14(9):1210-5. PubMed ID: 9327450
[TBL] [Abstract][Full Text] [Related]
11. Scale-up of in vitro permeation assay data to human intestinal permeability using pore theory.
Kataoka M; Iwai K; Masaoka Y; Sakane T; Sakuma S; Yamashita S
Int J Pharm; 2011 Jul; 414(1-2):69-76. PubMed ID: 21596118
[TBL] [Abstract][Full Text] [Related]
12. Transepithelial transport of a natural cholinesterase inhibitor, huperzine A, along the gastrointestinal tract: the role of ionization on absorption mechanism.
Burshtein G; Friedman M; Greenberg S; Hoffman A
Planta Med; 2013 Mar; 79(3-4):259-65. PubMed ID: 23345165
[TBL] [Abstract][Full Text] [Related]
13. Paracellular porosity and pore size of the human intestinal epithelium in tissue and cell culture models.
Linnankoski J; Mäkelä J; Palmgren J; Mauriala T; Vedin C; Ungell AL; Lazorova L; Artursson P; Urtti A; Yliperttula M
J Pharm Sci; 2010 Apr; 99(4):2166-75. PubMed ID: 19827099
[TBL] [Abstract][Full Text] [Related]
14. Transport mechanisms of flavanone aglycones across Caco-2 cell monolayers and artificial PAMPA membranes.
Kobayashi S; Nagai T; Konishi Y; Tanabe S; Morimoto K; Ogihara T
J Pharm Pharmacol; 2012 Jan; 64(1):52-60. PubMed ID: 22150672
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
16. Prediction of the oral absorption of low-permeability drugs using small intestine-like 2/4/A1 cell monolayers.
Tavelin S; Taipalensuu J; Söderberg L; Morrison R; Chong S; Artursson P
Pharm Res; 2003 Mar; 20(3):397-405. PubMed ID: 12669959
[TBL] [Abstract][Full Text] [Related]
17. Artificial membrane assays to assess permeability.
Faller B
Curr Drug Metab; 2008 Nov; 9(9):886-92. PubMed ID: 18991585
[TBL] [Abstract][Full Text] [Related]
18. QSAR study on permeability of hydrophobic compounds with artificial membranes.
Fujikawa M; Nakao K; Shimizu R; Akamatsu M
Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
[TBL] [Abstract][Full Text] [Related]
19. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
